Abstract
The immense diversity of microorganisms has remained largely untapped, especially with regard to bioprospecting. Through their isolation, microbes attain a substantial monetary value which microbial domain Biological Resource Centers (mBRCs) preserve in a highly cost-effective manner. Typically, mBRCs are publicly funded in order to provide quality-controlled, and well-characterized microbial resources and data, at low cost to researchers. The present chapter outlines the preconditions and scenarios for mBRCs to expand their traditional tasks and enter the field of bioprospecting. It appears most promising to generate information on the biosynthetic potential of novel types of microorganisms through extended characterization, metabolic profiling, and genome analyses. Particular challenges are an improved access to the vast uncharted microbial biodiversity, the compliance with new legal requirements, and the efficient linking to private industry as a novel stakeholder. A business plan is developed herein that proposes to join the expertise of different mBRCs to create a platform that provides a “one-stop-shop” with restricted access to a large number of well-characterized, pre-screened microbial resources in a legally compliant manner. As a typical and inherent weakness, the limited public funding of mBRCs often will not permit an expansion of tasks through the existing funding alone. Revenues generated from sales of even high value microbial resources to bioindustry rarely will cover costs. Therefore, alternative funding could be sought from the government agencies in charge of the bioeconomy that traditionally are not stakeholders of mBRC, and through the participation of mBRCs in dedicated funding programs for bioprospecting.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ABSCH, Acess and Benefit Sharing Clearing House (2015). https://absch.cbd.int/
Ando K, Jin TU, Funabiki R, Wu L, Thoetkiattikul H, Lee J-S, Techapattaraporn B, Changthavorn T (2014) Network of international exchange of microbes under the ACM (NIEMA) – a transfer and exchange system of microbes for microbial resource centres for non-commercial puposes according to the CBD and the nagoya protocol. Microbiol Cult Collect 30:85–96
Baker BJ, Dick GJ (2013) Omics approaches in microbial ecology: charting the unknown. Microbe 8:353–360
Baltz RH (2006) Marcel faber roundtable: is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration? J Ind Microbiol Biotechnol 33:507–513
Bérdy J (2005) Bioactive microbial metabolites. J Antibiot 58:1–26
Bills G, Dombrowski A, Paláez F, Polishook J, An Z (2002) Recent and future discoveries of pharmacologically active metabolites from tropical fungi. In: Watling R, Frankland JC, Ainsworth AM, Isaac S, Robinson CH (eds) Tropical mycology, Vol. 2, Micromycetes. CAB International, Wallingford, pp. 165–194
Blackwell M (2011) The fungi: 1, 2, 3 … 5.1 million species? Am J Bot 98:426–438
Butler MS (2005) Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 22:162–195
CBD, Convention on Biological Diversity (2015). Nagoya protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization (ABS) to the convention on biological diversity. http://www.cbd.int/abs/doc/protocol/nagoya-protocol-en.pdf
Chin Y-W, Balaunas MJ, Chai HB, Kinghorn AD (2006) Drug discovery from natural sources. AAPS J 8:E239–E253
Cooper MA, Shlaes D (2011) Fix the antibiotics pipeline. Nature 472:32
Curtis TP, Sloan WT, Scannell JW (2002) Estimating prokaryotic diversity and its limits. Proc Natl Acad Sci U S A 99:10494–10499
Dawyndt P, Vancanneyt M, De Meyer H, Swings J (2005) Knowledge accumulation and resolution of data inconsistencies during the integration of microbial information sources. IEEE Trans Knowl Data Eng 17:1111–1126
Dykhuizen DE (1998) Santa Rosalia revisited: why are there so many species of bacteria? Ant Van Leeuwenhoek 73:25–33
Ernst & Young (2014) Beyond borders – biotechnology industry report, http://www.ey.com/GL/en/Industries/Life-Sciences/EY-beyond-borders-unlocking-value
ECCO, European Culture Collection’s Organisation (2015). www.eccosite.org
EU (2014). Regulation (EU) No 511/2014 of the European Parliament and of the Council of 16 April 2014 on compliance measures for users from the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization in the Union. http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32014R0511
EuropaBio™ (2014) Annual Report 2013-2014, http://www.europabio.org/europabio-annual-report-2013-2014
Foesel BU, Rohde M, Overmann J (2013) Blastocatella fastidiosa gen. nov., sp. nov., isolated from semiarid savanna soil – the first described species of Acidobacteria subdivision 4. Syst Appl Microbiol 36:82–89
Fritze D, Smith D, Martin D (2010). Third intermediate report on the GBRCN demonstration project. Germany: GBRCN Secretariat. ISBN 978-3-00-031458-2
Furman JL, Stern S (2011) Climbing atop the shoulders of giants: the impact of institutions on cumulative research. American. Econ Rev 101:1933–1963
GCM, Global Catalogue of Microorganisms (2015) http://gcm.wfcc.info
Genilloud O (2014) The re-emerging role of microbial natural products in antibiotic discovery. Ant van Leeuwenhoek 106:173–188
Glaser KB, Mayer AM (2009) A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Biochem Pharmacol 78:440-448
Hindra TH, Yang D, Rudolf JD, Xie P, Xie G, Teng Q, Lohman JR, Zhu X, Huang Y, Zhao L-X, Jiang Y, Duan Y, Shen B (2014) Strain prioritization for natural product discovery by a high-throughput real-time PCR method. J Nat Prod 77:2296–2303
IMS Health Market Prognosis (2012) http://www.imshealth.com/deployedfiles/ims/Global/Content/Corporate/Press%20Room/Top-Line%20Market%20Data%20&%20Trends/2011%20Top-line%20Market%20Data/Regional_Pharma_Market_by_ Spending_2011-2016.pdf
Jaspers E, Overmann J (2004) The ecological significance of “microdiversity”: identical 16S rRNA gene sequences represent bacteria with highly divergent genomes and physiology. Appl Environ Microbiol 70:4831–4839
Jeske O, Jogler M, Petersen J, Sikorski J, Jogler C (2013) From genome mining to phenotypic microarrays: planctomycetes as source for novel bioactive molecules. Ant Van Leeuwenhoek 104:551–567
Kate KT, Laird SA (1999) The commercial use of biodiversity: access to genetic resources and benefit sharing . Earthscan Publications Ltd., Londonpp 398
Kirk PM, Cannon PF, Minter DW, Stalpers JA (2008) Dictionary of the fungi, 10th edn. CAB International, Wallingford
SP Lapage, PHA Sneath, EF Lessel, VBD Skerman, HPR Seeliger, WA Clark (1992) International code of nomenclature of bacteria. Bacteriological code, 1990 revision. ASM Press, Washington
Lomes CJ, Bateman RP, Johnson DL, Langewald J, Thomas M (2001) Biological control of locusts and grasshoppers. Annu Rev Entomol 46:667–702
LPSN, List of prokaryotic names with standing in nomenclature (2015) http://www.bacterio.net/-number.html#total
Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci 31:255–265
Maymó-Gatell X, Chien Y-T, Gossett JM, Zinder SH (1997) Isolation of a bacterium that reductively dechlorinates tetrachloroethene to ethene. Science 276:1568–1571
MIRRI, Microbial Resource Reseach Infrastructure (2015) http://www.mirri.org/home.html
Miyazaki M (2006) Economic value of microbial resources. Microbiol Cult Collect 22:15–19
Nett M, Erol Ö, Kehraus S, Köck M, Krick A, Eguereva E, Neu E, König GM (2006) Siphonazole, an unusual metabolite from Herpetosiphon sp. Angew Chem Int Ed 45:3863–3867
Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335
OECD (2004) Guidance for the operation of Biological Resource Centres (BRCs) [‘Biological Research Centres’ is erroneously printed on the cover of this document], OECD. http://www.oecd.org/science/biotech/23547743.pdf
Overmann J (2012) Principles of enrichment, isolation, cultivation, and preservation of bacteria. In: Rosenberg E, Stackebrandt E, DeLong EF, Thompson F, Lory S (eds) The prokaryotes, vol 4. Springer, New York. doi:10.1007/978-3-642-30194-0_7
Overmann J (2015) Significance and future role of microbial resource centers. Syst Appl Microbiol 38:258–265
PhRMA (2012) Pharmaceutical research and manufacturers of America, drug discovery and development: understanding the R&D process, www.innovation.org
Rocha J, Peixe L, Gomes NCM, Calado R (2011) Cnidarians as a source of new marine bioactive compounds – an overview of the last decade and future steps for bioprospecting. Mar Drugs 9:1860–1886
Quaiser A, Ochsenreiter T, Lanz C, Schuster SC, Treusch AH, Eck J, Schleper C (2003) Acidobacteria form a coherent but highly diverse group within the bacterial domain: evidence from environmental genomics. Mol Microbiol 50:563–575
Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glöckner FO (2013) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41(Database issue): D590-596
Rosselló-Móra R, Amann RI (2015) Past and future species definitions for Bacteria and Archaea. Syst Appl Microbiol 38:209–216
Salazar O, González I, Genilloud O (2002) New genus-specific primers for the PCR identification of novel isolates of the genera Nocardiopsis and Saccharothrix. Int J Syst Evol Microbiol 52:1411–1421
Sanford RA, Cole JR, Tiedje JM (2002) Characterization and description of Anaeromyxobacter dehalogenans gen. nov., sp. nov., an aryl-halorespiring facultative anaerobic myxobacterium. Appl Environ Microbiol 68:893–900
Scannell JW, Blnackley A, Boldon H, Warrington B (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11:191–200
Schüngel M, Stackebrandt E, Bizet C, Smith D (2013) MIRRI – The microbial resource research infrastructure: managing resources for the bio-economy. EMBnet J 19(1):5–8. (http://journal.embnet.org/index.php/embnetjournal/article/view/706)
Simpson DR (1997) Biodiversity prospecting: shopping the wilds is not the key to conservation. Resour Futur 126:12–15
Singh SB, Zhang C, Zink DL, Herath K, Ondeyka J, Masurekar P, Jayasuriya H, Goetz MA, Tormo JR, Vicente F, Martín J, González I, Genilloud O (2013) Occurrence, distribution, dereplication and efficient discovery of thiazolyl peptides by sensitive-resistant pair screening. J Antibiot 66:599–607
Smith D (2012) Culture collections. Adv Appl Microbiol 79:73–118
Smith D (2014) Culture collections. In: Batt CA, Tortorello ML (eds) Encyclopedia of food microbiology, vol 1. Elsevier Ltd/Academic Press, Amsterdam, pp. 546–552
Smith D, Fritze F, Stackebrandt E (2013) Public service collections and biological resource centres of microorganisms. In: Rosenberg E, De Long EF, Lory S, Stackebrandt E, Thompson F (eds) The prokaryotes – prokaryotic biology and symbiotic associations. Springer, Berlin/Heidelberg, pp. 267–304
Smith D, Mc Cluskey K, Stackebrandt E (2014) Culture collection funding models and BRC business plans, SpringerPlus 3, 81. http://www.springerplus.com/content/3/1/81
Söhngen C, Bunk B, Podstawka A, Gleim D, Overmann J (2014) BacDive – the bacterial diversity metadatabase. Nucleic Acids Res 42:D592–D599
Stackebrandt E (2010) Diversification and focusing: strategies of microbial culture collections. Trends Microbiol 18:283–287
Stackebrandt E, Smith D, Casaregola S, Varese GC, Verkleij G, Lima N, Bridge P (2014) Deposit of microbial strains in public service collections as part of the publication process to underpin good practice in science. Springer Plus 3:208
Sugawara H, J Ma, Miyazaki S, Shimura J, Takishima Y (eds) (1993) World directory of collections of cultures of microorganisms. ISBN 4-930813-56-5, 1152 pp
Tuama EÓ, Deck J, Dröge G, Döring M, Field D, Kottmann R, Ma J, Mori H, Morrison N, Sterk P et al (2012) Meeting report: Hackathon-workshop on Darwin Core and MIxS standards alignment (February 2012). Stand Genomic Sci 7:166–170
WDCM, World Data Center for Microorganisms (2015). Culture collections information worldwide. http://www.wfcc.info/ccinfo/statistics/
Weissmann KJ, Müller R (2010) Myxobacterial secondary metabolites: bioactivities andmodes-of-action. Nat Prod Rep 27:1276–1295
WFCC, World Federation of Culture Collections (2015) http://gcm.wfcc.info/overview/
Wilson MC, Mori T, Rückert C, Uria AR, Helf MJ, Takada K et al (2014) An environmental bacterial taxon with a large and distinct metabolic repertoire. Nature 506:58–62
WIPO, World Intellectual Property Organization (2015) ( http://www.wipo.int/ipstats/en/statistics/micros/index.html )
Wu D, Hugenholtz P, Mavromatis K, Pukall R, Dalin E, Ivanova NN et al (2009) A phylogeny-driven genomic encyclopaedia of bacteria and archaea. Nature 462:1056–1060
Wu L, Sun Q, Sugawara H, Yang S, Zhou Y, McCluskey K, Vasilenko A, Suzuki K-I, Ohkuma M, Lee Y, Robert V, Ingsriswang S, Guissart F, Philippe D, Ma J (2013) Global catalogue of microorganisms (gcm): a comprehensive database and information retrieval, analysis, and visualization system for microbial resources. BMC Genomics 14:933
Xie P, Ma M, Rateb ME, Shaaban KA, Yu Z, Huang SX, Zhao LX, Zhu X, Yan Y, Peterson RM, Lohman JR, Yang D, Yin M, Rudolf JD, Jiang Y, Duan Y, Shen B (2014) Biosynthetic potential-based strain prioritization for natural product discovery: a showcase for diterpenoid-producing actinomycetes. J Nat Prod 77:377–387
Yilmaz P, Kottmann R, Field D, Knight R, Cole JR, Amaral-Zettler L, Gilbert JA, Karsch-Mizrachi I, Johnston A, Cochrane G et al (2011) Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat Biotechnol 29:415–420
Acknowledgements
This work was funded by grants of the German Federal Ministry of Science and Education (BMBF) through the German Centre of Infection Research (DZIF) (grant 8000-105-3). Additional support was by the European Commission through funding of the preparatory phase of the Microbial Resource Research Infrastructure (MIRRI, No. 312251) and through the FP7-project ‘Marine Microorganisms: Cultivation Methods for Improving their Biotechnological Applications’ (MaCuMBA, No. 311975) and is gratefully acknowledged. We thank Amber Hartman Scholz for useful comments and suggestions regarding the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Overmann, J., Smith, D. (2017). Microbial Resource Centers Contribute to Bioprospecting of Bacteria and Filamentous Microfungi. In: Paterson, R., Lima, N. (eds) Bioprospecting. Topics in Biodiversity and Conservation, vol 16. Springer, Cham. https://doi.org/10.1007/978-3-319-47935-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-47935-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47933-0
Online ISBN: 978-3-319-47935-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)